Clinical Research Directory

Inclusion Criteria: * Patient with histologically confirmed pancreatic adenocarcinoma. * Disease at a resectable, borderline, locally advanced, initially metastatic, or recurrent stage after surgery * Diagnosis between January 1, 2003, and December 31, 2030. * First-line treatment with chemotherapy and/or radiotherapy and/or clinical trials. * Age ≥ 18 years. * Written informed consent Exclusion Criteria: * Patient under guardianship, curatorship, or judicial protection. * Pregnant or breastfeeding women. * Any medical, psychological, or social situation that could prevent compliance with the protocol as assessed by the investigator. * Refusal to participate in the study